Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule of Deferred Tax Assets (Details)

v3.25.2
Schedule of Deferred Tax Assets (Details) - USD ($)
Jun. 30, 2025
Jun. 30, 2024
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 5,149,067 $ 3,738,702
Other assets and liabilities 204,750 226,530
Stock- based compensation 549,745 457,501
Capitalized research and development expenditures 2,075,163 1,985,585
Gross deferred tax assets 7,978,725 6,408,318
Valuation allowance (7,978,725) (6,408,318)
Total deferred tax assets, net of valuation allowance